Related Experiment Video
Updated: Jun 23, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
HbA1c and the Risk of Lower Limb Ulcers Among Diabetic Patients: An Observational and Genetics Study
Guojun Guo1, Yunlong Guan2, Yuhuan Chen2
1Department of Hand Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Insights
High blood sugar, measured by glycated hemoglobin (HbA1c), significantly increases the risk of developing lower limb ulcers in diabetic patients. Maintaining HbA1c below 53 mmol/mol is recommended to reduce ulcer incidence.
Area of Science:
- Endocrinology
- Diabetology
- Vascular Medicine
Background:
- Lower limb ulcers are a severe complication of diabetes mellitus.
- The precise relationship between glycated hemoglobin (HbA1c) and lower limb ulceration requires further investigation.
Purpose of the Study:
- To comprehensively assess the association between HbA1c levels and the risk of lower limb ulcers in diabetic individuals.
- To explore potential causal links using observational and Mendelian randomization (MR) methods.
Main Methods:
- A prospective cohort study involving 23,434 diabetic patients from the UK Biobank.
- Utilized Cox proportional hazard models and one-sample Mendelian randomization analyses to evaluate HbA1c-ulcer risk association.
Main Results:
- Over 290,677 person-years, 1101 lower limb ulcer cases were recorded.
- Higher HbA1c levels demonstrated a dose-dependent increase in lower limb ulcer risk, particularly above 53 mmol/mol.
- Mendelian randomization analyses indicated a positive, though not statistically significant, association.
Conclusions:
- Elevated HbA1c levels are a significant risk factor for lower limb ulcers in the diabetic population.
- An HbA1c target below 53 mmol/mol is suggested to mitigate the incidence of diabetic foot ulcers.
Abstract:
Aims: A lower limb ulcer is a serious complication of diabetes. The association between glycated hemoglobin (HbA1c) and lower limb ulcers needs further clarification. We aimed to comprehensively evaluate the relationship between HbA1c and lower limb ulcer risk in diabetic patients through multivariable-adjusted observational analyses and Mendelian randomization (MR) approaches. Methods: This prospective cohort study included 23,434 individuals with prevalent diabetes in the UK Biobank. The Cox proportional hazard model was used to evaluate the association between HbA1c levels and lower limb ulcer risk. Furthermore, a one-sample MR analysis was conducted to explore the potential causal effect. Results:Over a follow-up period of 290,677 person-years (median length: 13.3 years), 1101 lower limb ulcers cases were documented. The multivariable-adjusted hazard ratios across categories of HbA1c of ≤ 42, 42-53, 53-64, 64-75, 75-86, and > 86 mmol/mol were 0.93 (0.76-1.15), 1.00, 1.24 (1.05-1.46), 1.98 (1.65-2.39), 2.68 (2.13-3.37), and 4.52 (3.62-5.65), respectively. The restrictive cubic spline model showed that lower limb ulcer risk increased steeply when HbA1c concentration exceeded 53 mmol/mol. One-sample linear and nonlinear MR analyses provided a positive but not significant association between genetically proxied HbA1c and lower limb ulcer risk among diabetic patients. Conclusions: High HbA1c levels increase the risk of lower limb ulcers in diabetic patients. MR analyses validated the positive but not significant association between genetically proxied HbA1c levels and lower limb ulcer risk. The results recommended an HbA1c goal of < 53 mmol/mol to decrease the incidence of diabetic ulcers.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Hyperglycemia
Diabetic Foot Ulcer

